文献速递临床试验与 GCP流行病学与生物统计

基于贝叶斯模型平均与尖峰-平板先验的随机篮式试验剂量优化设计

A Randomized Basket Trial Design for Dose Optimization Based on Bayesian Model Averaging Using Spike-and-Slab Priors.
PubMed 文献 · Stat Med · 2026-01-01

本文针对FDA Project Optimus的剂量优化要求及篮式试验在早期临床试验中的趋势,提出一种基于贝叶斯模型平均、同时考虑疗效与毒性结局的剂量范围篮式试验设计,其中适应症与剂量水平定义篮式。模拟研究显示,在篮式间疗效异质的多种情景下,该方法统计功效更高、I类错误控制更好、最优剂量选择更精确且节省样本量。

要点

  • 该设计同时考虑疗效与毒性,适应症与剂量水平共同定义篮式。
  • 方法显式处理篮式间响应率的异质性。
  • 模拟显示其统计功效更高、I类错误控制更好、最优剂量选择更精确。

核心结论

  • 所提出的基于贝叶斯模型平均的剂量范围篮式试验设计在篮式间疗效异质情景下优于其他方法。

研究设计与样本

  • 提出一种基于贝叶斯模型平均、考虑疗效与毒性结局的剂量范围篮式试验设计,其中适应症与剂量水平定义篮式。
  • 采用模拟研究评估所提方法的性能。

主要发现

  • 模拟研究显示,在篮式间疗效异质的多种情景下,所提方法统计功效更高。
  • 模拟研究显示,所提方法I类错误控制更好。
  • 模拟研究显示,所提方法最优剂量选择更精确。
  • 模拟研究显示,所提方法节省样本量。

临床怎么用

  • 在早期临床试验中,可考虑采用该设计同时评估多适应症与多剂量水平的疗效和毒性,以支持剂量优化。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The FDA initiated Project Optimus and issued guidance for dose optimization, recommending randomized parallel dose-response cohorts to generate additional data at promising dose levels and implying that different dosages may be needed for different indications. In addition to dose optimization, with recent advancements in precision medicine and cancer biology, the development of cancer treatments has shifted toward the search for agents targeted to specific molecular profiles that may appear in more than one type of cancer. The basket trials are clinical trial designs that enable the simultaneous assessment of a new treatment in multiple indications. Concerning the FDA's dose optimization perspective and the recent trend of basket trials in early-phase clinical trials, this paper proposes a dose-ranging basket trial design based on a Bayesian model-averaging approach considering efficacy and toxicity outcomes, where indications and dose levels define baskets. A key benefit of the proposed approach is that it explicitly accounts for the possible heterogeneity of response rates among baskets. Our simulation study shows that the proposed approach outperforms other methods, offering higher statistical power, better control of Type I error rates, precise optimal dose selection, and sample size savings in various scenarios with heterogeneous treatment effects between baskets.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Yimer BB, Takeda K. A Randomized Basket Trial Design for Dose Optimization Based on Bayesian Model Averaging Using Spike-and-Slab Priors. Stat Med. 2026. PMID: 42601178. doi:10.1002/sim.70700

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。